✦ LIBER ✦

A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis

✍ Scribed by Peter Mollee; Campbell Tiley; Ilona Cunningham; John Moore; H. Miles Prince; Paul Cannell; Steve Gibbons; Jill Tate; Sanjoy Paul; Helen Mar Fan; Devinder S. Gill

Book ID: 114714661
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 74 KB
Volume: 157
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09080.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interim analysis of a phase II study of

Interim analysis of a phase II study of risk-adapted intravenous melphalan followed by adjuvant dexamethasone (D) and thalidomide (T) for newly diagnosed patients with systemic al amyloidosis (AL)

✍ A.D. Cohen; P. Zhou; L. Reich; S. Fircanis; L. Drake; C. Hedvat; J. Teruya-Felds 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Phase II trial and pharmacokinetic asses

Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer

✍ David C. Smith; Duncan I. Jodrell; Merrill J. Egorin; Roy M. Ambinder; Eleanor G 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 701 KB

Febrile reactions occurring with second

Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a ‘melphalan recall’ reaction

✍ Rosenzweig, M; Seldin, D C; Remick, D G; Skinner, M; Quillen, K; Oran, B; Finn, 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 154 KB

Febrile Reactions Occurring With Second

Febrile Reactions Occurring With Second Cycle of High Dose Melphalan and Stem Cell Transplantation in Patients With AL Amyloidosis: A “Melphalan Recall” Reaction

✍ M.A. Rosenzweig; D.C. Seldin; D. Remick; M. Skinner; K. Quillen; B. Oran; K.T. F 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Phase II study of intravenous melphalan

Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck

✍ Merrill S. Kies; David Grinblatt; Melissa Runge-Morris; Richard Blough; Arletric 📂 Article 📅 1994 🏛 Springer US 🌐 English ⚖ 242 KB

A phase II study of 5-day intravenous az

A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes

✍ Mike G. Martin; Richard A. Walgren; Elizabeth Procknow; Geoffrey L. Uy; Keith St 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views